Condition
Orthostatic Hypotension, Dysautonomic
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 3 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
3 shownFeasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.NCT06831500 · 2025-07-18
RECRUITINGEpidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's DiseaseNCT06920134 · 2025-07-03
RECRUITINGBlood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic FailureNCT02591173 · 2016-02-01
TERMINATEDCommon interventions
Leading sponsors
Trial status mix
RECRUITING2
TERMINATED1
Phase mix
EARLY_PHASE11
NA1
PHASE11
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.